About us
We have assembled an experienced team with strong scientific, clinical and commercial expertise.
InnoSIGN has years of experience in drug discovery, CDx development, commercial launch, and market access.
Meet the team
Eric Lindquist
Chief Executive Officer
Marianna Polonsky
VP of Commercial Strategy, BD & Market Access
Yvonne Wesseling-Rozendaal
Director of Data Science
Laurent Holtzer
VP of Engineering
Anne van Brussel
Application Scientist
Dianne van Strijp
Product Application Specialist
Gwen Sülter
Business Operations ManagerBoard of Directors
Allan May
Chairman - Life Science Angels
Eric Lindquist
CEO InnoSIGN
Evan Castiglia
Thuja Capital
Mark Oldroyd
Independent Board Member
Paul Vernooij
Observer BOM